JV of Alembic receives approval for Lidocaine Ointment
JV of Alembic receives approval for Lidocaine Ointment

JV of Alembic receives approval for Lidocaine Ointment

Shohini Nath Article rating: 5.0

Alembic Pharma’s joint venture, Aleor Dermaceuticals has received USFDA approval for Lidocaine Ointment USP. Shares of the company were up by almost 2 per cent intraday.

SJVN receives repeat order in Satluj basin
SJVN receives repeat order in Satluj basin

SJVN receives repeat order in Satluj basin

Gayathri Udyawar Article rating: 5.0

The company has received a fresh order from the state government of Himachal Pradesh allotting the Jangi-Thopan-Powari (780 MW) project on BOOT basis.

Godrej Properties partners with Hero Cycles
Godrej Properties partners with Hero Cycles

Godrej Properties partners with Hero Cycles

Apurva Joshi Article rating: 5.0

Godrej Fund Management and Godrej Properties have entered into a joint venture agreement with Hero Cycles to develop a prime office development on Golf Course Road, Gurgaon. Godrej Fund Management is the real estate private equity arm of the Godrej Group, and Godrej Properties Limited is one of India's leading real estate developers.

Lupin receives USFDA approval for two drugs
Lupin receives USFDA approval for two drugs

Lupin receives USFDA approval for two drugs

Dnyanada Kulkarni Article rating: 5.0

Pharma major Lupin received approval from the USFDA for two important drugs namely - Clomipramine Hydrochloride Capsules and Potassium Chloride for oral solution USP. 

SPARC soars 8 per cent on the back of successful research data
SPARC soars 8 per cent on the back of successful research data

SPARC soars 8 per cent on the back of successful research data

Dnyanada Kulkarni Article rating: 5.0

The shares of Sun Pharma Advanced Research Company (SPARC) gained 8 per cent in Monday's morning session as the company announced the positive results of its pivotal bioequivalence study for a cancer drug.

Are solution-based mutual funds good?
Are solution-based mutual funds good?

Are solution-based mutual funds good?

Henil Shah Article rating: 5.0

SEBI, in mutual funds categorization, has created a separate category for mutual funds which are specifically dedicated to an individual’s financial goals such as child education and retirement. These MFs are known as solution-based mutual funds. But is it worth investing in them? Let’s find out.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 4.0

The markets on November 26, 2018 opened up. BSE Sensex is trading at 35,059.57, up by 78.55 points and the Nifty is trading at 10,538.95, up by 12.20 points. 

BEML receives order worth Rs. 3,015 crore, stock surges
BEML receives order worth Rs. 3,015 crore, stock surges

BEML receives order worth Rs. 3,015 crore, stock surges

Amir Shaikh Article rating: 5.0

BEML a miniratna company which manufactures rail coaches and spares, and mining equipment has bagged order DMRC for the supply of 378 metro coaches (63 metro trains) to Mumbai Metro Line - 2 and 7 projects. 

RSS
First31323133313431353137313931403141Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR